Autologous Fat in Peripheral Nerve Injury
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04653129 |
|
Recruitment Status :
Not yet recruiting
First Posted : December 4, 2020
Last Update Posted : December 7, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Nerve Injury | Procedure: Autologous Fat Grafting Procedure: Primary Nerve Repair | Not Applicable |
Traumatic injuries to peripheral nerves are a frequent finding after hand trauma. High morbidity after nerve injuries mainly affects the younger and working population, with consequent decrease in life quality and productivity .
Even in direct nerve repair and microsurgical nerve coaptation, regeneration is often suboptimal with incomplete target reinnervation. Suboptimal outcome is attributed to axonal degeneration, fibrotic scar formation, and neuromas at the site of injury.
The use of adipose tissue has become very popular in tissue engineering and reconstructive surgery in recent years. It is proposed as a "regenerative tool" for various tissues, including peripheral nerves, because it offers an effective and minimally invasive procedure for obtaining stem cells.
Unprocessed fat grafting can provide a simple approach to improve peripheral nerve regeneration by means of neoangiogenesis & inflammatory response modulation. Furthermore, it serves as a good protective barrier in peripheral nerve surgery, reducing fibrosis and adhesions.
A recent study advocated by Tuncel et al, concluded that combined use of autologous fat graft with surgical repair methods induced significantly better regeneration in rats [3]. In another study by Kilic et al, using adipose tissue flap in a crush injury model in rats was found to be superior to other groups in myelin thickness, nerve fiber density, axon count, and functional recovery at 4 weeks. They concluded that fat tissue seems to promote nerve regeneration because of its stem cell content.
To our knowledge, no prior studies have examined the use of fat graft in peripheral nerve repair in humans. So, the investigators proposed this clinical study to evaluate the outcomes of primary nerve repair combined with autologous fat graft in peripheral nerve injuries.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 44 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | the assessment of outcome measures will be performed by a dedicated surgeon not involved in the surgery or preoperative patient evaluation |
| Primary Purpose: | Treatment |
| Official Title: | Use of Autologous Fat to Improve Functional Outcomes After Upper Limb Nerve Injuries |
| Estimated Study Start Date : | January 2021 |
| Estimated Primary Completion Date : | January 2022 |
| Estimated Study Completion Date : | January 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Group (A): Primary nerve repair with autologous fat graft
Standard nerve repair will be performed with 9/0 nylon sutures, under magnification by an operating microscope with autologous fat grafting around site of repair
|
Procedure: Autologous Fat Grafting
Procedure: Primary Nerve Repair Standard Epineural nerve repairs will be performed with 9/0 nylon sutures, under magnification by an operating microscope. |
|
Active Comparator: Group (B): Standard primary nerve repair
Standard nerve repair will be performed with 9/0 nylon sutures, under magnification by an operating microscope without fat grafting.
|
Procedure: Primary Nerve Repair
Standard Epineural nerve repairs will be performed with 9/0 nylon sutures, under magnification by an operating microscope. |
- Modified British Medical Research Council, sensory grading [ Time Frame: 6-12 months ]standardized clinical assessment of sensory function using two-point discrimination and monofilament testing by a score from S0 to S4; the higher score indicates better sensation
- Modified British Medical Research Council, motor grading [ Time Frame: 6-12 months ]standardized clinical assessment of motor function on a scale from M0 to M5; the higher score indicates better strength.
- Nerve conduction study [ Time Frame: 6-12 months ]measure for amplitude of response, latency of response and velocity of response measurements.
- Disability of the Arm, Shoulder, and Hand (DASH) score [ Time Frame: 6-12 months ]self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The DASH consists mainly of a 30-item disability/symptom scale, scored 0 (no disability) to 100 (most severe disability)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 16 Years to 65 Years (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Acute median or ulnar nerve lacerations below elbow
Exclusion Criteria:
- Old Nerve lacerations > 48 hours
- Nerve gap which requires nerve grafting
- Psychosocial issues that would limit participation and compliance
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04653129
| Contact: Ahmed S Sharaf, MsC | 01090619155 ext +2 | ahmed.sharaf90@aun.edu.eg |
| Study Director: | Tarek A El-Gammal, MD | Assiut University Hospital - Orthopaedics & Traumatology Dept. | |
| Study Chair: | Youssef S Hassan, MD | Assiut University Hospitals - Plastic Surgery Dept. | |
| Study Director: | Awny M Asklany, MD | Assiut University Hospitals - Plastic Surgery Dept. | |
| Principal Investigator: | Ahmed S Sharaf, MsC | Assiut University Hospitals - Plastic Surgery Dept. |
| Responsible Party: | Ahmed ElSayed Sharaf Ahmed, Assistant Lecturer, Assiut University |
| ClinicalTrials.gov Identifier: | NCT04653129 |
| Other Study ID Numbers: |
Fat for Nerve Injury |
| First Posted: | December 4, 2020 Key Record Dates |
| Last Update Posted: | December 7, 2020 |
| Last Verified: | December 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
fat graft autologous fat peripheral nerve injury |
|
Peripheral Nerve Injuries Wounds and Injuries Peripheral Nervous System Diseases |
Neuromuscular Diseases Nervous System Diseases Trauma, Nervous System |

